Mason Street Advisors LLC boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 0.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 122,929 shares of the company’s stock after purchasing an additional 650 shares during the period. Mason Street Advisors LLC’s holdings in Colgate-Palmolive were worth $8,426,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of CL. BB&T Corp lifted its position in shares of Colgate-Palmolive by 1.2% in the 1st quarter. BB&T Corp now owns 274,086 shares of the company’s stock worth $18,786,000 after purchasing an additional 3,129 shares during the period. Ffcm LLC lifted its position in shares of Colgate-Palmolive by 5.6% in the 4th quarter. Ffcm LLC now owns 63,206 shares of the company’s stock worth $3,762,000 after purchasing an additional 3,325 shares during the period. Nachman Norwood & Parrott Inc lifted its position in shares of Colgate-Palmolive by 1.9% in the 1st quarter. Nachman Norwood & Parrott Inc now owns 11,101 shares of the company’s stock worth $761,000 after purchasing an additional 209 shares during the period. Strs Ohio lifted its position in shares of Colgate-Palmolive by 1.9% in the 1st quarter. Strs Ohio now owns 415,958 shares of the company’s stock worth $28,509,000 after purchasing an additional 7,713 shares during the period. Finally, River & Mercantile Asset Management LLP purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $7,765,000. Institutional investors own 75.95% of the company’s stock.

Several equities research analysts have recently weighed in on CL shares. UBS Group upped their price target on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, March 29th. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $82.00 price target for the company in a research report on Wednesday, May 1st. ValuEngine raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. Morgan Stanley upped their price target on shares of Colgate-Palmolive from $62.00 to $68.00 and gave the stock an “equal weight” rating in a research report on Monday, April 29th. Finally, Macquarie set a $57.00 price target on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Tuesday, January 29th. One investment analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $69.69.

In related news, Chairman Ian M. Cook sold 19,500 shares of the stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $71.20, for a total transaction of $1,388,400.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Noel R. Wallace sold 84,351 shares of the stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $71.89, for a total transaction of $6,063,993.39. Following the sale, the chief executive officer now directly owns 279,023 shares of the company’s stock, valued at approximately $20,058,963.47. The disclosure for this sale can be found here. Insiders have sold 335,211 shares of company stock valued at $23,724,495 in the last three months. 1.14% of the stock is currently owned by corporate insiders.

NYSE:CL opened at $71.53 on Wednesday. Colgate-Palmolive has a 52 week low of $57.41 and a 52 week high of $73.10. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.07 and a quick ratio of 0.74. The company has a market cap of $61.79 billion, a P/E ratio of 24.08, a PEG ratio of 4.72 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, April 26th. The company reported $0.67 EPS for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.01. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The company had revenue of $3.88 billion during the quarter, compared to analysts’ expectations of $3.86 billion. During the same quarter in the prior year, the company posted $0.74 earnings per share. Colgate-Palmolive’s revenue for the quarter was down 2.9% compared to the same quarter last year. As a group, equities analysts anticipate that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were given a dividend of $0.43 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. The ex-dividend date was Wednesday, April 17th. This represents a $1.72 dividend on an annualized basis and a yield of 2.40%. Colgate-Palmolive’s dividend payout ratio is presently 57.91%.

ILLEGAL ACTIVITY NOTICE: This piece was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.watchlistnews.com/mason-street-advisors-llc-has-8-43-million-position-in-colgate-palmolive-cl/3018678.html.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Further Reading: How can you know how many shares are floating?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.